Search Nonprofits

JDRF's mission is to find a cure for type 1 diabetes and its complications through the support of research. It is also committed to developing new and better treatments that improve the lives of people with type 1 diabetes in the near term and keep them healthy while we advance toward a cure. JDRF’s promise is to progressively remove the impact of T1D from the lives of those living with the disease until it is no longer a threat to them or their families.

Established in 1985, The ALS Association is dedicated to leading the fight to treat and cure ALS through global research and nationwide advocacy while also empowering people with Lou Gehrig's Disease and their families to live fuller lives by providing them with compassionate care and support. The Association builds hope and enhances the quality of life while aggressively searching for new treatments and a cure, through global research, providing assistance for people with ALS through a nationwide network of chapters, coordinating multidisciplinary care through certified clinical care centers, and fostering government partnerships.

Race to Erase MS is dedicated to the treatment and ultimate cure of Multiple Sclerosis. Funding research is the core focus of the Foundation and all funds raised support our Center Without Walls program, a selected network of the nation's top MS research centers. This nationwide collaboration of physicians and scientists are on the cutting-edge of innovative research programs, working as a team on therapeutic approaches to eradicate MS. In addition to combating MS through research in a clinical environment, we hope to increase awareness by educating the public about this mystifying disease.

Bridging the healing gap, leaving a legacy of healing for future generations. To end the cycle of complex relational trauma by providing the safety, life skills, relational education, and reparative experiences a survivor needs so they can create new habits and experience optimum health in every area of life.

The Arc of the Capital Area, a nonprofit organization, is committed to empowering central Texans with intellectual and developmental disabilities and their families through compassionate case management and innovative programs.

Has a mission that is dedicated to achieving economic and social justice for all deaf people by providing financial, educational and social opportunities to end the economic exploitation of deaf people. The foundation envisions a world free of audism where everyone experiences full humanity and celebrates sign language. To achieve the mission and vision, the foundation focuses on four goals: consulting, outreach, networking and grants. Grants are the primary goal and the heart of the foundation and funding is provided for those areas: arts, activism, education, media, and research.

The mission of The POLG Foundation is to support and accelerate research to find effective treatments and a cure for PolG-related mitochondrial disorders.

The Hospital for Sick Children Foundation, affectionately known as SickKids Foundation, is the largest non-governmental granting agency in child health in Canada. Established in 1972, SickKids Foundation has granted over $300 million to The Hospital for Sick Children and over $60 million to researchers across the country. Through its National Grants Program, SickKids Foundation is the only granting program with a national, multi-year initiative to study two understudied but important areas of child health: the role of complementary and alternative health care and child health, and to study home care and children and youth. We have invested our community’s contributions in outstanding patient care, research and education. We believe there is no one else in Canada as dedicated as we are to eliminating the gap between what is happening in child health research, education and training, and what should be happening.

BUILDING ON THE BOLD LEGACY OF HENRI TERMEER, WHO PIONEERED GROUNDBREAKING TREATMENTS FOR RARE DISEASES, THE TERMEER FOUNDATION CONNECTS LIFE SCIENCE INNOVATORS AND CATALYZES THE CREATION OF NEW MEDICINES. THE FOUNDATION'S NETWORK OF EMERGING AND ESTABLISHED HEALTHCARE INNOVATORS CULTIVATES TOMORROW'S LEADERS AND LEVERAGES THEIR COLLECTIVE EXPERTISE TO SOLVE COMPLEX PROBLEMS IN DRUG DEVELOPMENT AND ACCESSIBILITY. THE FOUNDATION ALSO INTEGRATES ITS NETWORK WITH ACADEMIC INSTITUTIONS, NONPROFITS, REGULATORY AGENCIES AND OTHER ORGANIZATIONS ACROSS THE GLOBAL HEALTHCARE ECOSYSTEM TO PROVIDE EXPERT COUNSEL, STIMULATE INNOVATION, ELIMINATE BARRIERS TO PROGRESS, AND ULTIMATELY CONNECT THE WORLD OF HEALTHCARE UNTIL EVERY PATIENT HAS A CURE. TOGETHER, EVERYTHING IS POSSIBLE.

The Diabetes Foundation (DF) has been empowering individuals struggling with prediabetes, type 1, type 2 or gestational diabetes since 1990. By providing access to critical resources and medication necessary to remain healthy, the Diabetes Foundation is a safety net for New Jersey residents in need. Our unique program serves children, parents, adults, and caregivers regardless of income or healthcare coverage. Our goal is to improve our participant's health by making it simpler to build a personalized healthcare plan that fits within the parameters in which they live. The generous support and funding from patrons and sponsors allows the Diabetes Foundation to offer our services to the community for free.

CSNK2A1 Foundation is focused on finding a cure for Okur-Chung Neurodevelopmental Syndromeand ensuring affected individuals have the opportunities and supports necessary for happy and full lives.

Galactosemia Foundation Inc. (formerly, Parents of Galactosemic Children) is a non-profit charitable organization that advocates for people with galactosemia and their families. Founded in February 1985, Galactosemia Foundation helps provide affected families information on Galactosemia and facilitates networkings between families, clinicians, and researchers. Our mission and objectives: - To educate, support and provide advocacy for those affected by Galactosemia. - To network with professionals to inspire the treatment and advanced research of Galactosemia